Introduction
Lately, our stock market has been a bit like a rollercoaster. Trump’s tariff talks have stirred things up.
It leaves many of us wondering where to park our money safely. That’s why I’m excited to dive into something interesting today.
The Quant Small Cap Fund. It is one of India’s most talked-about mutual fund schemes from the small cap space.
It has reshuffled its portfolio for July 2025.
They’ve added some fresh small-cap stocks that caught my attention. Even better, a few of these are trading below the price Quant bought them at (you can jump here to see the list).
Could this be a golden opportunity in these choppy times? Let’s explore in this post.
Why Quant’s Moves Matter
Quant Mutual Fund is a big name in the Indian investment world. Their Small Cap Fund is known for bold choices and solid returns over time.
When they buy new stocks, it’s worth a second look.
The fund’s latest update shows they’ve added five new names to their portfolio. These aren’t just random picks. They reflect Quant’s strategy of hunting for growth in the small-cap space.
What’s more interesting for me is that, they are doing it when the market feels shaky. For a person like me, this action of Quant of pointing towards quality, small cap, value stocks.
With tariffs and global uncertainty in the air, their confidence in these stocks makes me curious. Maybe they see something we should too.
List Of Stocks to Watch – New Additions
Let’s talk about the fresh faces in Quant’s portfolio. They’ve brought the following stocks:
- Ethos Ltd.,
- Marathon Nextgen Realty,
- Anthem Biosciences,
- Gland Pharma, and
- Digitide Solution.
Each one has a unique story.
- Ethos Ltd., a luxury watch retailer, is a small player with big potential as India’s affluent class grows.
- Marathon Nextgen Realty focuses on real estate development, a sector that could bounce back with the right policy push.
- Anthem Biosciences and Gland Pharma are in healthcare, tapping into a resilient industry.
- Digitide Solution is a tech firm which adds a modern twist to the Quant’s portfolio.
Quant has also increased its holdings in Jio Finance and Priram Enterprises, but these are anyhow know names. So I do think there is must value-juice left in them (till market corrects in a major way).
These companies might not be on everyone’s radar yet, but Quant’s faith in them is a signal worth noting, right?
| SL | Name | % Holding | 1M Change (Qty K) | 1M Change (Value Cr.) | Average Buy Price | Current Price | Discuount (%) |
| 1 | Piramal Enterprises | 1.84% | 4,335.57 | 542.73 | 1,251.81 | 1,156.80 | -7.59% |
| 2 | Jio Finance | 6.17% | 60,489.69 | 1,991.62 | 329.25 | 329.55 | 0.09% |
| 3 | Ethos Ltd. | 0.07% | 71.90 | 19.85 | 2,760.78 | 2,833.30 | 2.63% |
| 4 | Marathon Nextgen Realty | 1.32% | 5,484.91 | 389.87 | 710.80 | 655.65 | -7.76% |
| 5 | Antehm Bioscience | 0.95% | 3,682.93 | 279.59 | 759.15 | 757.05 | -0.28% |
| 6 | Gland Pharma | 0.44% | 621.28 | 128.28 | 2,064.77 | 1,952.90 | -5.42% |
| 7 | Exicom Tele-Systems | 0.25% | 4,343.42 | 72.24 | 166.32 | 137.83 | -17.13% |
| 8 | Digitide Solution | 0.13% | 1,685.30 | 39.20 | 232.60 | 198.95 | -14.47% |
Stocks Trading at a Discount To Quant’s Average Buy Price
Now, here’s where it my analysis becomes more useful and valuable.
- Some of these stocks are trading below the average price Quant paid for them.
Take the following cases for instance:
- Marathon Nextgen Realty: Quant bought it at Rs.710.80 per share, but it’s now at Rs.655.65. That’s a discount of about -7.7%.
- Gland Pharma: It is another case in hand. Quant bought its shares at Rs.2,064.77, now at Rs.1,952.90. It is a dip of around -5%.
- Piramal Enterprises: It is an existing holding with increased stakes. This stock sits at Rs.1,156.80 against an average buy price of Rs.1,251.81. It is about -7.5% down from its average bought price.
- Exicom Tele-Systems and Digitide Solutions: These are very small cap stocks with market cap of Rs.1,920 crore and Rs.2930 crore respectively. These two stocks are down by about -15% from the quant’s average buy price.
In a choppy market, these price drops could be a chance to buy some quality valued stocks.
Isn’t it smart to grab quality names when they’re on sale? Though, it is true that I’m not buying these stocks for now. I’ll wait longer till Trump & Putin’s meet on 15-August-2025 in Alaska. Moreover, I’ll keep a watch on how my Stock Engine app is rendering its Intrinsic Value and Overall Scores for these stocks in case the price slips further down.
| SL | Name | Overall Score |
| 1 | Piramal Enterprises (PEL) | 42.81 / 100 |
| 2 | Jio Finance | 43.00 / 100 |
| 3 | Ethos Ltd. | 42.31 / 100 |
| 4 | Marathon Nextgen Realty | 61.75 / 100 |
| 5 | Antehm Bioscience | Not Listed |
| 6 | Gland Pharma | 54.25 / 100 |
| 7 | Exicom Tele-Systems | Not Listed |
| 8 | Digitide Solution | Not Listed |
[Note: This is not a stock recommendation. I’m jsut sharing a data for information purpose only.]
Why These Stocks Could Be Interesting
So, why did these stocks catch my eye?
- First, Quant’s track record gives them credibility. They don’t just throw money around. Their research suggests these companies have growth potential. Since 03-Apr-2020 (in last ~5.5 years), this mutual fund scheme has compounded at a CAGR of 47.9% per annum. It means, the capital grew by 8 times in less than 5.5 years. In my last 16-17 years of stock investing, I’ve not seen a mutual fund scheme generating such returns.
- Second, small caps often fly under the radar, offering room for big gains if the market turns favorable. With tariff fears cooling off, sectors like healthcare and real estate might see a revival.
- Third, buying stocks (either these or any other quality stocks for a matter), at a discount lowers our entry cost. Imagine picking up a Rs.10 stock for Rs.Rs.2.
Of course, small caps can be volatile (extremely risky). Only a few investors (one in one thousand) will have the appetite to make money out of them. What appetite? Ability to hold when the small-caps corrects by 40% odd percent and stays there for 1.5-2 years at a stretch.
In this mindset, we get to see a list of stocks. They have the Quant’s backing. It is natural to feel that these picks are not just a gamble but more like a calculated bet.
So what I’m confused? Because of the low Overall Scores of these stocks (check this list again).
Conclusion
Now, let’s get real.
The market isn’t in the best mood right now. Trump’s tariff threats have spooked investors globally.
India’s small-cap stocks, sensitive to trade shifts, have felt the heat. They are falling, even some quality names.
This volatility can scare people off. But this is also true that it also creates opportunities. When prices drop, value investors get a chance to step in.
Quant’s move to add these stocks in July suggests they’re betting on a recovery.
It’s a thought worth chewing on as we watch how things unfold.
But in stock investing, especially when you are dealing with small-caps, it necessary to take a statutory pause.
Remember, Quant’s portfolio data is a guide, not a guarantee. We must check the companies’ fundamentals ourselves.
Look at their earnings, debt, and growth plans. My Stock Engine has algorithm’s written to uncover such queries:
- Is the stock’s financial health score good?
- Is the stock poised to grow faster?
- Is the company profitable or not?
- How safe is the company from its competitors?
It is also essential consider our risk appetite. Say I have Rs.100,000 available for investing today. I use it to buy a small cap stocks. In coming days, say the Trump’s Tariff scenario gets worse and my capital shrinks from Rs.100,000 to Rs.35,000. Do I have the appetite to hold till the stock recovers? Remember, this waiting time can be 1-2 years.
If you’re new to this, small-caps shall be avoided. I see new investors investing only small-small amounts in stocks, I think, they do it to test the waters. In a way it is a good approach, but most of them are not aware about how long they must wait to turn red into green.
These two abilities decide your risk appetite to invest in risky stocks:
- Able see your holdings go deep in red (-50%) without panicking. and
- To ride the waiting time (1-2 years), without selling.
If you have this kind of risk appetite, small-caps is for you. Else, leave it to Quant to the investing for you.
Happy investing, friends! Let’s navigate this market together.
